Johnson & Johnson (JNJ)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011726
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:298
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infectious, cardiovascular and metabolic diseases areas; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, surgery, diabetes care and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and consumer products through retail outlets and distributors. The company provides its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson (JNJ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 8
List of Figures 11
Johnson & Johnson, Medical Equipment, Deals By Year, 2011 to YTD 2017 12
Johnson & Johnson, Medical Equipment Deals By Type, 2011 to YTD 2017 13
Johnson & Johnson, Medical Equipment, Deals By Region, 2011 to YTD 2017 14
Johnson & Johnson, Medical Equipment, Deals By Market, 2011 to YTD 2017 15
Johnson & Johnson, Medical Equipment, Deals Summary, 2011 to YTD 2017 17
Johnson & Johnson, Medical Equipment, Deal Details 31
Asset Purchase 31
DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 31
Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To US$62 Million 32
Venture Financing 33
DayTwo Raises USD12 Million in Series A Financing 33
Hyalex Orthopaedics Raises USD16 Million in Series A Financing 34
Grail Raises USD914 Million in First Tranche of Series B Financing 35
Atlas Genetics Raises USD35 Million in Series D Financing 37
OrthoSpace Raises USD7 Million in Venture Financing 39
ReVision Optics Raises USD32 Million in Venture Financing 40
CVRx Raises USD57.7 Million in Series G Financing 42
RefleXion Medical Raises Additional USD6 Million in Series B Financing 44
Torax Medical Raises USD25 Million in Series E Financing 45
WellDoc Raises USD7.5 Million in Extended Series B Financing 47
Cala Health Raises USD18 Million in Series A Financing Round 48
Raises USD45 Million in Series A Financing 49
V-Wave Raises USD28 Million in Venture Financing 50
CartiHeal Raises USD15 Million in Venture Financing Round 51
Atlas Genetics Raises USD20 Million in Series C Financing 52
NeuWave Medical Raises USD4.76 Million in Venture Financing 54
Inivata Raises USD6.5 Million in Venture Financing 55
Biocartis Raises USD85 Million in Venture Financing 56
PowerVision Raises USD30 Million in Series D Financing 57
Inspire Medical Systems Raises USD40 Million In Series E Financing 59
Torax Medical Raises US$13.7 Million In Venture Financing 61
Biocartis Raises US$40.5 Million In Series E Financing 62
CVRx Raises US$42 Million In Series F Financing 64
ReVision Optics Raises US$55 Million In Venture Financing 66
Cardiac Dimensions Raises US$2.4 Million In Venture Financing 68
Nevro Raises US$48 Million In Series C Financing 70
Biocartis Raises US$44.7 Million In Series D Financing 72
Torax Medical Raises US$30 Million In Series D Financing 74
NeuWave Medical Raises US$14 Million In Series B Financing 76
Astute Medical Raises US$40.4 Million In Series C Financing 77
Mitralign Raises US$35 Million In Series D Financing 79
Direct Flow Medical Secures USD0.28 Million in Venture Funding 81
Coherex Medical Secures USD16.5 Million in Venture Funding 82
PowerVision Raises Additional US$12.5 Million In Series C Venture Financing 83
Pronota Raises US$4.8 Million In Series C Financing 85
Clarimedix Raises Financing From COSAT 87
Biocartis Secures US$96 Million In Series C Financing Round 88
Olive Medical Secures US$1 Million In Venture Financing 90
Atlas Genetics Raises US$27 Million In Series B Financing 91
Nevro Secures US$58 Million In Financing 93
Spinal Modulation Secures US$30 Million In Series D Financing 95
LifeBond Secures US$20 Million In Series C Venture Financing 97
TORAX Medical Secures US$4 Million In Financing 99
Calibra Medical Secures US$7.1 Million In Financing Round 100
NeuWave Medical Raises US$6 Million In Venture Financing 101
Astute Medical Secures Additional US$13 Million In Series B Venture Financing 102
Calibra Medical Secures US$1 Million In Venture Financing Round 103
NeoTract Raises US$26 Million In Venture Financing Round 104
Zeo Raises USD12.3 Million in Extended Series C Financing 105
Private Equity 106
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 106
Welsh, Carson, Anderson & Stowe Acquires GetWellNetwork, Provider Of Interactive Patient Care Solutions 108
Water Street Healthcare Partners Acquires OraPharma 110
Partnerships 111
Janssen Research and Development Enters into Licensing Agreement with Optibrium for StarDrop 111
KFx Medical Enters into Licensing Agreement with DePuy Mitek 112
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 113
Anika Therapeutics Enters Into Licensing Agreement With DePuy Mitek 114
Genomic Health Enters into Research Agreement with Janssen Pharma 115
DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 116
DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 117
Adaptive Biotech Enters into Partnership with Janssen Biotech 118
Sebia Enters into Agreement with Janssen Biotech 119
Johnson & Johnson Enters into Research Agreement with Orthocell 120
Karolinska Institutet Partners with Johnson & Johnson Companies 121
Aspect Biosystems Partners with DePuy Synthes 122
Rest Devices Enters into Agreement with Johnson & Johnson Consumer 123
WellDoc Enters into Agreement with LifeScan 124
Codman Neuro Enters into Distribution Agreement with InNeuroCo 125
Materialise Enters into Distribution Agreement with DePuy Synthes 126
Johnson & Johnson Services Partners with HP 127
LifeScan Enters into Agreement with WellDoc 128
Biosense Webster Enters into Agreement with Northwestern University 129
Medos International Enters into Agreement with Rainbow Medical 130
Ethicon Endo-Surgery Enters into Agreement with HistoSonics 131
Janssen Pharma Enters into Agreement with Cue 132
Johnson & Johnson Forms Joint Venture with Google Life Sciences 133
DePuy Synthes Enters into Agreement with Radlink 134
Royal Philips Enters into Co-Development Agreement with Janssen Pharma 135
Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 136
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 137
DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 138
Codman & Shurtleff Enters into Distribution Agreement with Pulsar Vascular 139
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 140
Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 141
BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 142
Janssen Research & Development Enters into Research Agreement with MD Biosciences 143
DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 144
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 145
Myriad Enters Into Research Agreement With Janssen Research & Development 146
DePuy Synthes Expands Co-Marketing Agreement With Brainlab 147
Coherex Medical Enters Into Distribution Agreement With Biosense Webster 148
Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 149
Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 150
OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 151
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 152
Philips Enters Into Technology Integration Agreement With Biosense Webster 153
DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 154
Abbott Medical Optics and ShapeTech Partner To Develop New Polymers For Intraocular Lenses 155
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 156
Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 157
Insulet Enters Into Technology Integration Agreement With LifeScan 158
Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 159
Cellnovo Enters Into Technology Integration Agreement With LifeScan 160
Skyline Diagnostics Enters Into Research Collaboration With Johnson & Johnson Pharma 161
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 162
Synthes Enters Into Co-Development Agreement With Eli Lilly 163
Stereotaxis Enters Into An Agreement With Biosense Webster 164
Synthes Enters Into An Agreement With Materialise 165
Sermo Enters Into Co-Development Agreement With Janssen Global Services 166
Biocartis Enters Into Co-Development Agreement With Janssen Pharmaceutica 167
Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 168
Stereotaxis Amends Co-Development Agreement With Biosense Webster 169
Cenix BioScience Enters Into Licensing Agreement With Janssen 170
Equity Offering 171
Sphere Medical Completes Private Placement Of Shares For US$5 Million With Johnson & Johnson 171
Debt Offering 172
Johnson & Johnson Completes Public Offering Of Notes Due 2033 For US$650 Million 172
Johnson & Johnson Completes Public Offering Of Notes Due 2018 For US$600 Million 174
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$400 Million 176
Johnson & Johnson Completes Public Offering Of Notes Due 2023 For US$550 Million 178
Johnson & Johnson Completes Public Offering Of Notes Due 2043 For US$500 Million 180
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$800 Million 182
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$750 Million 184
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2021 For US$450 Million 186
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$1,000 Million 188
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2041 For US$300 Million 190
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2013 For US$500 Million 192
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2016 For US$900 Million 194
Johnson & Johnson Completes Public Offering Of 0.70% Senior Unsecured Notes Due 2013 For US$500 Million 196
Asset Transactions 198
Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 198
Centinel Spine to Acquire Prodisc Assets from DePuy Synthes 200
Menarini-Silicon Biosystems Acquires Cellsearch CTC System from Janssen Diagnostics 201
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 202
Johnson & Johnson To Sell Distal Volar Radius System To Biomet 203
Symmetry Medical Completes Acquisition Of Surgical Instruments Business From Codman & Shurtleff For US$165 Million 204
Acquisition 206
Johnson & Johnson Medical to Acquire Surgical Process Institute 206
Johnson & Johnson Acquires Sightbox 207
Abbott Medical Optics Acquires TearScience 208
Johnson & Johnson Acquires Actelion for USD30 Billion 209
Johnson & Johnson, Novartis and Takeda Pharma May Acquire Hypermarcas 211
Codman Neuro Acquires Neuravi 213
Ethicon Acquires Torax Medical 214
Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 215
Ethicon Endo-Surgery Acquires Megadyne Medical Products 216
Codman Neuro Acquires Pulsar Vascular 217
DePuy Orthopaedics Acquires BioMedical Enterprises 218
Ethicon Acquires NeuWave Medical from H.I.G. BioHealth Partners 219
Johnson & Johnson May Acquire Transenterix 220
Biosense Webster Acquires Coherex Medical 221
Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 222
DePuy Synthes Acquires Olive Medical 224
Johnson & Johnson Plans to Acquire Cardiovascular Company 225
ZOLL Medical Acquires CoAxia, Medical Device Company 226
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 228
Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 230
LifeScan Acquires Calibra Medical 231
Johnson & Johnson Completes Acquisition Of Synthes For US$19.7 Billion 232
Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 234
Ethicon Endo-Surgery Completes Acquisition Of SterilMed From Great Hill Partners And Primus Capital 235
Johnson & Johnson Plans To Acquire Manufacturer Of Heart Valves And Pumps 236
Kensey Nash Acquires Norian From Synthes 237
Johnson & Johnson May Acquire Medical Device And Diagnostics Companies 238
Johnson & Johnson – Key Competitors 239
Johnson & Johnson – Key Employees 240
Johnson & Johnson – Locations And Subsidiaries 242
Head Office 242
Other Locations & Subsidiaries 242
Recent Developments 260
Strategy And Business Planning 260
Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 260
Financial Announcements 261
Oct 17, 2017: Johnson & Johnson Reports 2017 Third-Quarter Results 261
Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 263
Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 265
Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 267
Apr 18, 2017: Johnson & Johnson Q1 net earnings down 269
Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 270
Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 272
Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 274
Apr 19, 2016: Johnson & Johnson Reports 2016 First-Quarter Results 276
Jan 26, 2016: Johnson & Johnson Reports 2015 Fourth-Quarter Results 278
Corporate Communications 280
Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 280
Jan 19, 2016: Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace 281
Legal and Regulatory 282
Nov 16, 2017: Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case 282
Nov 01, 2017: Decision Diagnostics CEO Offers Primary Update on Legal Proceedings, Potential Outcomes, History, and Synopsis on Its Strategic Suit Against J&J 283
Oct 04, 2017: U.S. Supreme Court Turns Back Appeal of $3.27 Million Ethicon Transvaginal Mesh Lawsuit Verdict, Bernstein Liebhard LLP Reports 284
Aug 07, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania, As Sixth Trial Kicks Off in Philadelphia, Bernstein Liebhard Reports 285
Jun 26, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania Mass Tort Program, As Court Schedules July Meeting, Bernstein Liebhard Reports 286
Aug 23, 2016: DECN Litigation Victory Against Johnson + Johnson, Launches Foothold in On-Line Retail Markets for Its Popular “Gen” Products 287
Aug 18, 2016: Deceptive marketing of surgical transvaginal mesh leads to trouble for Johnson & Johnson 288
Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 289
Feb 29, 2016: Baron & Budd Investigating Potential Lawsuits Against Johnson & Johnson Regarding Link Between Talcum Powder and Ovarian Cancer 290
Feb 03, 2016: Breaking News from Legal-Bay: Johnson & Johnson Settles for $120MM in First Big Transvaginal Mesh Settlement 291
Product News 292
Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek 2017 292
Sep 01, 2017: Ethicon Launches New Surgical Simulation Tool, ‘Touch Surgery’, Across EMEA 294
Other Significant Developments 295
Nov 03, 2017: Johnson & Johnson wins Contract for Medical Surgical Products 295
Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 296
Aug 03, 2016: Johnson & Johnson Medical Devices Companies Value-Based Solutions Help Health Systems Address Proposed Mandatory CMS Plan for Episode Payment Models 297
Appendix 298
Methodology 298
About GlobalData 298
Contact Us 298
Disclaimer 298

List of Tables
Johnson & Johnson, Medical Equipment, Key Facts, 2016 2
Johnson & Johnson, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Johnson & Johnson, Medical Equipment, Deals By Year, 2011 to YTD 2017 12
Johnson & Johnson, Medical Equipment Deals By Type, 2011 to YTD 2017 13
Johnson & Johnson, Medical Equipment, Deals By Region, 2011 to YTD 2017 14
Johnson & Johnson, Deals By Market, 2011 to YTD 2017 15
Johnson & Johnson, Medical Equipment, Deals Summary, 2011 to YTD 2017 17
DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 31
Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To US$62 Million 32
DayTwo Raises USD12 Million in Series A Financing 33
Hyalex Orthopaedics Raises USD16 Million in Series A Financing 34
Grail Raises USD914 Million in First Tranche of Series B Financing 35
Atlas Genetics Raises USD35 Million in Series D Financing 37
OrthoSpace Raises USD7 Million in Venture Financing 39
ReVision Optics Raises USD32 Million in Venture Financing 40
CVRx Raises USD57.7 Million in Series G Financing 42
RefleXion Medical Raises Additional USD6 Million in Series B Financing 44
Torax Medical Raises USD25 Million in Series E Financing 45
WellDoc Raises USD7.5 Million in Extended Series B Financing 47
Cala Health Raises USD18 Million in Series A Financing Round 48
Inivata Inivata Raises USD45 Million in Series A Financing 49
V-Wave Raises USD28 Million in Venture Financing 50
CartiHeal Raises USD15 Million in Venture Financing Round 51
Atlas Genetics Raises USD20 Million in Series C Financing 52
NeuWave Medical Raises USD4.76 Million in Venture Financing 54
Inivata Raises USD6.5 Million in Venture Financing 55
Biocartis Raises USD85 Million in Venture Financing 56
PowerVision Raises USD30 Million in Series D Financing 57
Inspire Medical Systems Raises USD40 Million In Series E Financing 59
Torax Medical Raises US$13.7 Million In Venture Financing 61
Biocartis Raises US$40.5 Million In Series E Financing 62
CVRx Raises US$42 Million In Series F Financing 64
ReVision Optics Raises US$55 Million In Venture Financing 66
Cardiac Dimensions Raises US$2.4 Million In Venture Financing 68
Nevro Raises US$48 Million In Series C Financing 70
Biocartis Raises US$44.7 Million In Series D Financing 72
Torax Medical Raises US$30 Million In Series D Financing 74
NeuWave Medical Raises US$14 Million In Series B Financing 76
Astute Medical Raises US$40.4 Million In Series C Financing 77
Mitralign Raises US$35 Million In Series D Financing 79
Direct Flow Medical Secures USD0.28 Million in Venture Funding 81
Coherex Medical Secures USD16.5 Million in Venture Funding 82
PowerVision Raises Additional US$12.5 Million In Series C Venture Financing 83
Pronota Raises US$4.8 Million In Series C Financing 85
Clarimedix Raises Financing From COSAT 87
Biocartis Secures US$96 Million In Series C Financing Round 88
Olive Medical Secures US$1 Million In Venture Financing 90
Atlas Genetics Raises US$27 Million In Series B Financing 91
Nevro Secures US$58 Million In Financing 93
Spinal Modulation Secures US$30 Million In Series D Financing 95
LifeBond Secures US$20 Million In Series C Venture Financing 97
TORAX Medical Secures US$4 Million In Financing 99
Calibra Medical Secures US$7.1 Million In Financing Round 100
NeuWave Medical Raises US$6 Million In Venture Financing 101
Astute Medical Secures Additional US$13 Million In Series B Venture Financing 102
Calibra Medical Secures US$1 Million In Venture Financing Round 103
NeoTract Raises US$26 Million In Venture Financing Round 104
Zeo Raises USD12.3 Million in Extended Series C Financing 105
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 106
Welsh, Carson, Anderson & Stowe Acquires GetWellNetwork, Provider Of Interactive Patient Care Solutions 108
Water Street Healthcare Partners Acquires OraPharma 110
Janssen Research and Development Enters into Licensing Agreement with Optibrium for StarDrop 111
KFx Medical Enters into Licensing Agreement with DePuy Mitek 112
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 113
Anika Therapeutics Enters Into Licensing Agreement With DePuy Mitek 114
Genomic Health Enters into Research Agreement with Janssen Pharma 115
DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 116
DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 117
Adaptive Biotech Enters into Partnership with Janssen Biotech 118
Sebia Enters into Agreement with Janssen Biotech 119
Johnson & Johnson Enters into Research Agreement with Orthocell 120
Karolinska Institutet Partners with Johnson & Johnson Companies 121
Aspect Biosystems Partners with DePuy Synthes 122
Rest Devices Enters into Agreement with Johnson & Johnson Consumer 123
WellDoc Enters into Agreement with LifeScan 124
Codman Neuro Enters into Distribution Agreement with InNeuroCo 125
Materialise Enters into Distribution Agreement with DePuy Synthes 126
Johnson & Johnson Services Partners with HP 127
LifeScan Enters into Agreement with WellDoc 128
Biosense Webster Enters into Agreement with Northwestern University 129
Medos International Enters into Agreement with Rainbow Medical 130
Ethicon Endo-Surgery Enters into Agreement with HistoSonics 131
Janssen Pharma Enters into Agreement with Cue 132
Johnson & Johnson Forms Joint Venture with Google Life Sciences 133
DePuy Synthes Enters into Agreement with Radlink 134
Royal Philips Enters into Co-Development Agreement with Janssen Pharma 135
Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 136
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 137
DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 138
Codman & Shurtleff Enters into Distribution Agreement with Pulsar Vascular 139
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 140
Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 141
BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 142
Janssen Research & Development Enters into Research Agreement with MD Biosciences 143
DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 144
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 145
Myriad Enters Into Research Agreement With Janssen Research & Development 146
DePuy Synthes Expands Co-Marketing Agreement With Brainlab 147
Coherex Medical Enters Into Distribution Agreement With Biosense Webster 148
Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 149
Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 150
OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 151
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 152
Philips Enters Into Technology Integration Agreement With Biosense Webster 153
DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 154
Abbott Medical Optics and ShapeTech Partner To Develop New Polymers For Intraocular Lenses 155
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 156
Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 157
Insulet Enters Into Technology Integration Agreement With LifeScan 158
Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 159
Cellnovo Enters Into Technology Integration Agreement With LifeScan 160
Skyline Diagnostics Enters Into Research Collaboration With Johnson & Johnson Pharma 161
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 162
Synthes Enters Into Co-Development Agreement With Eli Lilly 163
Stereotaxis Enters Into An Agreement With Biosense Webster 164
Synthes Enters Into An Agreement With Materialise 165
Sermo Enters Into Co-Development Agreement With Janssen Global Services 166
Biocartis Enters Into Co-Development Agreement With Janssen Pharmaceutica 167
Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 168
Stereotaxis Amends Co-Development Agreement With Biosense Webster 169
Cenix BioScience Enters Into Licensing Agreement With Janssen 170
Sphere Medical Completes Private Placement Of Shares For US$5 Million With Johnson & Johnson 171
Johnson & Johnson Completes Public Offering Of Notes Due 2033 For US$650 Million 172
Johnson & Johnson Completes Public Offering Of Notes Due 2018 For US$600 Million 174
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$400 Million 176
Johnson & Johnson Completes Public Offering Of Notes Due 2023 For US$550 Million 178
Johnson & Johnson Completes Public Offering Of Notes Due 2043 For US$500 Million 180
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$800 Million 182
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$750 Million 184
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2021 For US$450 Million 186
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2014 For US$1,000 Million 188
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2041 For US$300 Million 190
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2013 For US$500 Million 192
Johnson & Johnson Completes Public Offering Of Senior Unsecured Notes Due 2016 For US$900 Million 194
Johnson & Johnson Completes Public Offering Of 0.70% Senior Unsecured Notes Due 2013 For US$500 Million 196
Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 198
Centinel Spine to Acquire Prodisc Assets from DePuy Synthes 200
Menarini-Silicon Biosystems Acquires Cellsearch CTC System from Janssen Diagnostics 201
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 202
Johnson & Johnson To Sell Distal Volar Radius System To Biomet 203
Symmetry Medical Completes Acquisition Of Surgical Instruments Business From Codman & Shurtleff For US$165 Million 204
Johnson & Johnson Medical to Acquire Surgical Process Institute 206
Johnson & Johnson Acquires Sightbox 207
Abbott Medical Optics Acquires TearScience 208
Johnson & Johnson Acquires Actelion for USD30 Billion 209
Johnson & Johnson, Novartis and Takeda Pharma May Acquire Hypermarcas 211
Codman Neuro Acquires Neuravi 213
Ethicon Acquires Torax Medical 214
Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 215
Ethicon Endo-Surgery Acquires Megadyne Medical Products 216
Codman Neuro Acquires Pulsar Vascular 217
DePuy Orthopaedics Acquires BioMedical Enterprises 218
Ethicon Acquires NeuWave Medical from H.I.G. BioHealth Partners 219
Johnson & Johnson May Acquire Transenterix 220
Biosense Webster Acquires Coherex Medical 221
Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 222
DePuy Synthes Acquires Olive Medical 224
Johnson & Johnson Plans to Acquire Cardiovascular Company 225
ZOLL Medical Acquires CoAxia, Medical Device Company 226
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 228
Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 230
LifeScan Acquires Calibra Medical 231
Johnson & Johnson Completes Acquisition Of Synthes For US$19.7 Billion 232
Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 234
Ethicon Endo-Surgery Completes Acquisition Of SterilMed From Great Hill Partners And Primus Capital 235
Johnson & Johnson Plans To Acquire Manufacturer Of Heart Valves And Pumps 236
Kensey Nash Acquires Norian From Synthes 237
Johnson & Johnson May Acquire Medical Device And Diagnostics Companies 238
Johnson & Johnson, Key Competitors 239
Johnson & Johnson, Key Employees 240
Johnson & Johnson, Subsidiaries 242

★海外企業調査レポート[Johnson & Johnson (JNJ)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■

◆H&Iグローバルリサーチ株式会社のお客様(例)◆